Epigenomics AG: Reverse entry of the Epigenomics AG shares submitted for exchange


Following the failure of the offer condition under section 12.1.1 of the offer document the offer and the contracts which will come into existence with the offer are not effective.

As a result, Clearstream Banking1 is transferring with value date of 14 July 2017 the Epigenomics shares submitted for exchange from ISIN DE000A2E4K01 back to the original Epigenomics AG shares (ISIN DE000A11QW50).

Conversion of holdings

The positions in the registered shares from Epigenomics AG (ISIN DE000A11QW50) are created in unregistered positions (FMB).

Registration of shareholders in the share register required

The registration of shareholders in the share register of the issuer is implemented via the depository banks by re-registration in CASCADE-RS using the re-registration type "2" ("other not from purchase").


1. This Announcement is published by Clearstream Banking AG (CBF), registered office at Mergenthalerallee 61, 65760 Eschborn, Germany, registered with the Commercial Register of the District Court in Frankfurt am Main, Germany, under number HRB 7500.